Application 217936
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | OLAPARIB | OLAPARIB | TABLET | 150MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lynparza | OLAPARIB | AstraZeneca Pharmaceuticals LP | 741ff3e3-dc1a-45a6-84e5-2481b27131aa | 2025-07-10 | Warnings, Adverse reactions | OLAPARIB |